FDA Purple Book · Reference family
capromab pendetide (ProstaScint)
capromab pendetide is an FDA-licensed reference biologic from Aytu BioScience, Inc.. Reference exclusivity, biosimilar lineage, and published patents from official FDA Purple Book records.
0
Biosimilars
0
Interchangeables
0
Listed patents
1996
Reference approved
Reference product
351(a)BLA 103608
ProstaScint capromab pendetide
Aytu BioScience, Inc.
- Approved
- Oct 28, 1996
- Marketing
- Disc
- Center
- CDER
- Patents
- None listed
Exclusivity & patent cliffs
Approval, exclusivity, and published-patent expiration dates for capromab pendetide, in chronological order.
Reference approval
Approval date of the reference capromab pendetide product.
30 yr ago
Frequently asked questions
Are there biosimilars approved for capromab pendetide (ProstaScint)?
No 351(k) biosimilars or interchangeable biosimilars referencing capromab pendetide are listed in the FDA Purple Book yet.
Explore the full FDA Purple Book
Search every FDA-licensed biologic, biosimilar, and interchangeable with exclusivity timelines and patent records.